Damora Therapeutics is trading 5.01% up now at $28.18 as of September 11, 2026, primarily aligned with broad risk-on sentiment as investors assessed August inflation data.
- The S&P 500, Nasdaq Composite, and Dow Jones were each up more than 1%.
- No new company-specific announcement dated September 11 was identified.
- Its investor-relations page lists the latest release as a routine September 3 inducement-grant announcement; the move appears macro-driven rather than tied to a confirmed company catalyst.